other:Article Title: Form 10-Q
Article Snippet: 3 Table of Contents HOLOGIC, INC. CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) (In thousands) Three Months Ended Six Months Ended March29,2014 March30,2013 March29,2014 March30,2013 Net loss $ (16,765 ) $ (51,104 ) $ (22,116 ) $ (47,986 ) Changes in foreign currency translation adjustment (5,763 ) (8,288 ) (6,951 ) (6,319 ) Changes in unrealized holding (losses) gains on available-for-sale securities (1,048 ) 2,687 (2,228 ) 2,130 Changes in pension plans, net of taxes of $152 for the six months ended March29, 2014 — — (615 ) — Other comprehensive loss (6,811 ) (5,601 ) (9,794 ) (4,189 ) Comprehensive loss $ (23,576 ) $ (56,705 ) $ (31,910 ) $ (52,175 ) See accompanying notes.
Article Title: FORM 10-K
Article Snippet: F-27 Table of Contents Hologic, Inc. Notes to Consolidated Financial Statements (continued) (In thousands, except per share data) 3.
Article Title: FORM 10-K
Article Snippet: The historical distributor accounted for 12%, 24%, and 20% of product revenues for fiscal 2003, 2002, and F-13 Table of Contents Hologic, Inc. Notes to Consolidated Financial Statements (continued) (In thousands, except per share data) 2.
Article Title: FORM 10-K
Article Snippet: F-38 Table of Contents Hologic, Inc. Notes to Consolidated Financial Statements (continued) (In thousands, except per share data) 6.
Article Title: FORM 10-K
Article Snippet: F-48 Table of Contents Hologic, Inc. Notes to Consolidated Financial Statements (continued) (In thousands, except per share data) 15.
Article Title: FORM 10-K
Article Snippet: Table of Contents Hologic, Inc. Notes to Consolidated Financial Statements (continued) (In thousands, except per share data) 15.
Software:Article Title: For the fiscal year ended September 25, 2004
Article Snippet: In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Hologic, Inc. and subsidiaries at September 25, 2004 and September 27, 2003, and the consolidated results of their operations and their cash flows for each of the three years in the period ended September 25, 2004, in conformity with U.S. generally accepted accounting principles. .. /s/ Ernst & Young LLP Boston, Massachusetts November 1, 2004 F-1 Table of Contents Hologic, Inc. Consolidated Balance Sheets (In thousands, except per share data) September25,2004 September27,2003 Assets Current assets: Cash and cash equivalents $ 68,335 $ 45,177 Accounts receivable, less reserves of $2,757 and $3,477, respectively 48,409 43,831 Inventories 40,174 43,426 Prepaid expenses and other current assets 9,135 9,554 Total current assets 166,053 141,988 Property and equipment, at cost: Land 1,500 1,500 Buildings and improvements 13,697 13,607 Equipment and software 38,038 33,505 Furniture and fixtures 3,591 3,660 Leasehold improvements 2,728 2,637 59,554 54,909 Less—accumulated depreciation and amortization 26,677 22,803 32,877 32,106 Other assets: Patented technology, net of accumulated amortization of $6,761 and $5,732, respectively 824 1,702 Developed technology and know-how, net of accumulated amortization of $3,681 and $2,770, respectively 5,427 6,338 Goodwill 6,285 5,810 Other, net 285 659 12,821 14,509 Total assets $ 211,751 $ 188,603 Liabilities Current liabilities: Current portion of notes payable $ 475 $ 480 Accounts payable 10,546 10,819 Accrued expenses 20,970 17,387 Deferred revenue 13,013 9,440 Total current liabilities 45,004 38,126 Note payable, net of current portion 472 1,550 Commitments and contingencies (Note 8) Stockholders’ equity: Preferred stock, $0.01 par value–1,623 shares authorized; 0 shares issued — — Common stock, $0.01 par value–30,000 shares authorized; 20,585 and 19,966 shares issued, respectively 206 200 Capital in excess of par value 149,452 144,455 Retained earnings 18,196 6,032 Accumulated other comprehensive loss (1,115 ) (1,296 ) Treasury stock, at cost—45 shares (464 ) (464 ) Total stockholders’ equity 166,275 148,927 Total liabilities and stockholders’ equity $ 211,751 $ 188,603 See accompanying notes. .. F-2 Table of Contents Hologic, Inc. Consolidated Statements of Income (In thousands, except per share data) Years ended September25,2004 September27,2003 September28,2002 Revenues: Product sales $ 177,936 $ 156,734 $ 144,684 Service and other revenue 50,769 47,301 45,508 228,705 204,035 190,192 Costs and expenses: Cost of product sales 94,762 86,506 84,230 Cost of service and other revenue 48,574 43,949 34,146 Research and development 16,659 18,381 20,362 Selling and marketing 31,761 29,978 28,319 General and administrative 24,363 22,196 18,908 Restructuring and relocation — — 2,070 216,119 201,010 188,035 Income from operations 12,586 3,025 2,157 Interest income 540 685 573 Interest and other income (expense), net (199 ) (445 ) (2,980 ) Income (loss) before provision (benefit) for income taxes 12,927 3,265 (250 ) Provision (benefit) for income taxes 763 176 (429 ) Income before cumulative effect of change in accounting principle 12,164 3,089 179 Cumulative effect of change in accounting principle — (207 ) — Net income $ 12,164 $ 2,882 $ 179 F-3 Table of Contents Hologic, Inc. Consolidated Statements of Income (continued) (In thousands, except per share data) Years ended September25,2004 September27,2003 September28,2002 Basic income per common and common equivalent share: Income before cumulative effect of change in accounting principle $ 0.60 $ 0.16 $ 0.01 Cumulative effect of change in accounting principle — (0.01 ) — Net income $ 0.60 $ 0.15 $ 0.01 Diluted income per common and common equivalent share: Income before cumulative effect of change in accounting principle $ 0.57 $ 0.15 $ 0.01 Cumulative effect of change in accounting principle — (0.01 ) — Net income $ 0.57 $ 0.14 $ 0.01 Weighted average number of common shares outstanding: Basic 20,258 19,629 18,419 Diluted 21,296 20,130 19,192 See accompanying notes.
|
